What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to officially report Gilead Sciences' financial results for the quarter ended March 31, 2025, and to provide investors with access to the corresponding press release (Exhibit 99.1) that contains the detailed financial information.

Where can I find the detailed Q1 2025 financial results?

The detailed Q1 2025 financial results are available in the press release filed as Exhibit 99.1 to this 8-K. The press release itself includes tables and information on both GAAP and non-GAAP financial measures.

Why does Gilead present both GAAP and non-GAAP financial information?

Gilead presents non-GAAP financial measures because management believes they provide useful insights for investors and are used internally for operating, budgeting, and financial planning. However, these non-GAAP measures are not prepared under comprehensive accounting rules and should be used to supplement, not replace, the understanding of results reported under GAAP. A reconciliation between the two is provided in the press release.

Does this filing contain forward-looking statements or guidance?

This 8-K filing itself primarily announces the release of historical financial results. Any forward-looking statements, guidance, or projections would be contained within the press release (Exhibit 99.1) and should be reviewed carefully with the associated risk factors and disclosures.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) has filed an 8-K to report its financial results for the first quarter ended March 31, 2025. The company released its earnings on April 24, 2025, and this filing serves as a notification and includes the official press release detailing these results. Investors should refer to Exhibit 99.1 for the complete financial performance information. The press release provides both GAAP and non-GAAP financial measures. Gilead's management believes the non-GAAP figures offer valuable insights into operational performance and are used for internal planning, budgeting, and financial operations. A reconciliation between GAAP and non-GAAP results is available within the press release, allowing investors to fully understand the presented financial data.

Key Highlights

1Gilead Sciences (GILD) announced Q1 2025 financial results on April 24, 2025.
2The 8-K filing includes the press release (Exhibit 99.1) detailing the Q1 2025 financial performance.
3Financial results are presented on both GAAP and non-GAAP bases.
4Gilead's management utilizes non-GAAP measures for internal operational and financial planning.
5Investors are advised to review the press release for detailed financial information and reconciliations between GAAP and non-GAAP figures.
6The information provided in this 8-K is furnished and not deemed 'filed' under Section 18 of the Exchange Act, nor incorporated by reference into other filings.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Apr 24, 2025)

Summary

Key Highlights

Frequently Asked Questions